Lauren McCann
Wollongong Hospital(AU)
Publications by Year
Research Areas
Renal cell carcinoma treatment, Cancer Genomics and Diagnostics, Economic and Financial Impacts of Cancer, Renal and related cancers, Multiple and Secondary Primary Cancers
Most-Cited Works
- → Pazopanib in Locally Advanced or Metastatic Renal Cell Carcinoma: Results of a Randomized Phase III Trial(2010)2,472 cited
- → Pazopanib versus Sunitinib in Metastatic Renal-Cell Carcinoma(2013)1,903 cited
- → A randomised, double-blind phase III study of pazopanib in patients with advanced and/or metastatic renal cell carcinoma: Final overall survival results and safety update(2013)443 cited
- → Efficacy and Safety of Pazopanib in Patients With Metastatic Renal Cell Carcinoma(2009)292 cited
- → Overall Survival in Renal-Cell Carcinoma with Pazopanib versus Sunitinib(2014)272 cited
- → Pazopanib Efficacy in Renal Cell Carcinoma: Evidence for Predictive Genetic Markers in Angiogenesis-Related and Exposure-Related Genes(2011)148 cited
- → A randomized, double-blind phase III study of pazopanib in treatment-naive and cytokine-pretreated patients with advanced renal cell carcinoma (RCC)(2009)111 cited
- → Randomized, Open-Label, Phase III Trial Of Pazopanib Versus Sunitinib In First-Line Treatment Of Patients With Metastatic Renal Cell Carcinoma (MRCC): Results of the Comparz Trial(2012)84 cited
- → Patient preference between pazopanib (Paz) and sunitinib (Sun): Results of a randomized double-blind, placebo-controlled, cross-over study in patients with metastatic renal cell carcinoma (mRCC)—PISCES study, NCT 01064310.(2012)67 cited
- → Robust variable selection using least angle regression and elemental set sampling(2007)55 cited